Ingredient

Hydrogen [4-[[4-(diethylamino)phenyl][4-[ethyl[(3-sulphonatobenzyl)amino]-o-tolyl]methylene]-3-methylcyclohexa-2,5-dien-1-ylidene](ethyl)(3-sulphonatobenzyl)ammonium, sodium salt

⚠ EU Restricted

Identification

CAS Number 6505-30-2
EINECS / EC 229-390-2
CosIng Ref 30466
Chemical Name sodium 3-[[4-[(4-diethylazaniumylidenecyclohexa-2,5-dien-1-ylidene)-[4-[ethyl-[(3-sulfophenyl)methyl]amino]-2-methylphenyl]methyl]-N-ethyl-3-methylanilino]methyl]benzenesulfonate
IUPAC Name —
Formula C43H49N3NaO6S2+
Mol. Weight 791 g/mol
InChIKey RAMNYUMITLZMIC-UHFFFAOYSA-N

Function & Classification

EU Regulatory Status

🇪🇺
⚠ Restricted — EU Reg. 1223/2009 IV

Safety Profile

No toxicology data available yet for this ingredient.

Check SCCS opinions or CIR reports for published safety assessments.

NOAEL · Dermal Absorption % · Sensitization

Formulation Guidelines

Usage level, pH range, solubility and addition phase not yet available.

Usage Level % · Addition Phase · Solubility

Suppliers & Documents

Log in to see suppliers.

Log in or register to see suppliers and documents for Hydrogen [4-[[4-(diethylamino)phenyl][4-[ethyl[(3-sulphonatobenzyl)amino]-o-tolyl]methylene]-3-methylcyclohexa-2,5-dien-1-ylidene](ethyl)(3-sulphonatobenzyl)ammonium, sodium salt.

Documents

External Resources